Securities Registration (section 12(b)) (8-a12b)
October 17 2017 - 5:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE
SECURITIES EXCHANGE ACT OF 1934
AYTU
BIOSCIENCE, INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
|
47-0883144
|
(State of incorporation or organization)
|
|
(IRS Employer
|
|
|
Identification No.)
|
373 Inverness Parkway
Suite 206
Englewood, Colorado 80112
(Address of principal
executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the
Act:
Title of each class to be registered
|
|
Name of each exchange on which each class is to be registered
:
|
|
|
|
Common Stock, par value $0.0001 per share
|
|
The NASDAQ Stock Market LLC
|
If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.
þ
|
|
If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or €, please check the following box.
o
|
If
this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.
o
Securities Act registration statement or Regulation A offering
statement file number to which this form relates: _____________(if applicable):
Not applicable
Securities to be registered pursuant to Section 12(g) of the
Act:
None.
|
Item 1.
|
Description of Registrant’s Securities to be Registered.
|
The description of the common stock of
Aytu BioScience, Inc. (the “Registrant”), as included under the caption “Description of Capital Stock”
in the prospectus forming a part of the Registration Statement on Form S-1 (Registration No. 333-220351) (the “Registration
Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”), is incorporated by reference
herein. In addition, any description of such securities contained in a form of prospectus relating to the Registration Statement
subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed to be incorporated by reference
herein.
Under the Instructions as to Exhibits with
respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ
Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
|
AYTU BIOSCIENCE, INC.
|
|
|
|
|
|
|
|
|
|
Date: October 17, 2017
|
By:
|
/s/ Gregory Gould
|
|
|
|
Name: Gregory Gould
|
|
|
|
Title: Chief Financial Officer
|
|
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Apr 2024 to May 2024
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From May 2023 to May 2024